<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37340032</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Inhibitory effect of &#x3b2;-escin on Zika virus infection through the interruption of viral binding, replication, and stability.</ArticleTitle><Pagination><StartPage>10014</StartPage><MedlinePgn>10014</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10014</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-36871-1</ELocationID><Abstract><AbstractText>&#x3b2;-Escin is a mixture of triterpenoid saponins extracted from horse chestnut seeds that have diverse pharmacological activities, including anti-inflammation, anti-edematous, venotonic, and antiviral effects. In the clinical setting, &#x3b2;-escin is primarily used to treat venous insufficiency and blunt trauma injuries. The anti-Zika virus (ZIKV) activity of &#x3b2;-escin has not been explored. This study investigated the antiviral efficacy of &#x3b2;-escin on ZIKV and dengue virus (DENV) in vitro and then elucidated the underlying mechanism. The inhibitory effects of &#x3b2;-escin on viral RNA synthesis, protein levels, and infection ability were determined using qRT-PCR, Western blotting, and immunofluorescence assays, respectively. To further characterize how &#x3b2;-escin interferes with the viral life cycle, the time-of-addition experiment was performed. An inactivation assay was performed to determine whether &#x3b2;-escin affects ZIKV virion stability. To broaden these findings, the antiviral effects of &#x3b2;-escin on different DENV serotypes were assessed using dose-inhibition and time-of-addition assays. The results showed that &#x3b2;-escin exhibits anti-ZIKV activity by decreasing viral RNA levels, protein expression, progeny yield, and virion stability. &#x3b2;-Escin inhibited ZIKV infection by disrupting viral binding and replication. Furthermore, &#x3b2;-escin demonstrated antiviral activities against four DENV serotypes in a Vero cell model and prophylactic protection against ZIKV and DENV infections.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Zheng-Zong</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei, 114, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department and Graduate Institute of Pharmacology, National Defense Medical Center, Taipei, 114, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Hsin-Hsuen</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department and Graduate Institute of Pharmacology, National Defense Medical Center, Taipei, 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yen-Mei</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department and Graduate Institute of Pharmacology, National Defense Medical Center, Taipei, 114, Taiwan. ymlee@mail.ndmctsgh.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6805-41-0</RegistryNumber><NameOfSubstance UI="D004928">Escin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004928" MajorTopicYN="N">Escin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37340032</ArticleId><ArticleId IdType="pmc">PMC10282019</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-36871-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-36871-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duffy MR, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 2009;360:2536&#x2013;2543. doi: 10.1056/NEJMoa0805715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0805715</ArticleId><ArticleId IdType="pubmed">19516034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao-Lormeau VM, et al. Zika virus, French polynesia, South pacific, 2013. Emerg. Infect. Dis. 2014;20:1085&#x2013;1086. doi: 10.3201/eid2006.140138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2006.140138</ArticleId><ArticleId IdType="pmc">PMC4036769</ArticleId><ArticleId IdType="pubmed">24856001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-de-Brito A, et al. First detection of natural infection of Aedes aegypti with Zika virus in Brazil and throughout South America. Mem. Inst. Oswaldo Cruz. 2016;111:655&#x2013;658. doi: 10.1590/0074-02760160332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0074-02760160332</ArticleId><ArticleId IdType="pmc">PMC5066335</ArticleId><ArticleId IdType="pubmed">27706382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pielnaa P, et al. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology. 2020;543:34&#x2013;42. doi: 10.1016/j.virol.2020.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.01.015</ArticleId><ArticleId IdType="pubmed">32056845</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus MM, et al. Risk of Zika virus transmission by blood donations in Brazil. Hematol. Transfus. Cell Ther. 2018;40:250&#x2013;254. doi: 10.1016/j.htct.2018.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.htct.2018.01.011</ArticleId><ArticleId IdType="pmc">PMC6098187</ArticleId><ArticleId IdType="pubmed">30128434</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso D, et al. Potential sexual transmission of Zika virus. Emerg. Infect. Dis. 2015;21:359&#x2013;361. doi: 10.3201/eid2102.141363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2102.141363</ArticleId><ArticleId IdType="pmc">PMC4313657</ArticleId><ArticleId IdType="pubmed">25625872</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermillion MS, et al. Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat. Commun. 2017;8:14575. doi: 10.1038/ncomms14575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14575</ArticleId><ArticleId IdType="pmc">PMC5321801</ArticleId><ArticleId IdType="pubmed">28220786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jampol LM, Goldstein DA. Zika virus infection and the eye. JAMA Ophthalmol. 2016;134:535&#x2013;536. doi: 10.1001/jamaophthalmol.2016.0284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2016.0284</ArticleId><ArticleId IdType="pubmed">26865476</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonhard SE, et al. Guillain&#x2013;Barre syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study. J. Neurol. Sci. 2021;420:117272. doi: 10.1016/j.jns.2020.117272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117272</ArticleId><ArticleId IdType="pubmed">33360425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachira VK, Nascimento GL, Peixoto HM, de Oliveira MRF. Burden of disease of Guillain&#x2013;Barre syndrome in Brazil before and during the Zika virus epidemic 2014&#x2013;2016. Trop. Med. Int. Health. 2021;26:66&#x2013;81. doi: 10.1111/tmi.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13508</ArticleId><ArticleId IdType="pubmed">33151584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucey D, Cummins H, Sholts S. Congenital Zika syndrome in 2017. JAMA. 2017;317:1368&#x2013;1369. doi: 10.1001/jama.2017.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.1553</ArticleId><ArticleId IdType="pubmed">28384812</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NM, et al. Zika-associated birth defects reported in pregnancies with laboratory evidence of confirmed or possible Zika virus infection&#x2014;U.S. Zika Pregnancy and Infant Registry, December 1, 2015&#x2013;March 31, 2018. MMWR Morb. Mortal. Wkly. Rep. 2022;71:73&#x2013;79. doi: 10.15585/mmwr.mm7103a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7103a1</ArticleId><ArticleId IdType="pmc">PMC8774158</ArticleId><ArticleId IdType="pubmed">35051132</ArticleId></ArticleIdList></Reference><Reference><Citation>Prata-Barbosa A, Martins MM, Guastavino AB, Cunha A. Effects of Zika infection on growth. J. Pediatr. (Rio J) 2019;95(Suppl 1):30&#x2013;41. doi: 10.1016/j.jped.2018.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2018.10.016</ArticleId><ArticleId IdType="pubmed">30593788</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt DJ, Miner JJ. Consequences of congenital Zika virus infection. Curr. Opin. Virol. 2017;27:1&#x2013;7. doi: 10.1016/j.coviro.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.09.005</ArticleId><ArticleId IdType="pmc">PMC5814142</ArticleId><ArticleId IdType="pubmed">29080429</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, et al. A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomed. Pharmacother. 2022;146:112531. doi: 10.1016/j.biopha.2021.112531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112531</ArticleId><ArticleId IdType="pubmed">34906771</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda H, et al. Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol. Pharm. Bull. 1997;20:1092&#x2013;1095. doi: 10.1248/bpb.20.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.20.1092</ArticleId><ArticleId IdType="pubmed">9353571</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick RW. Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon. Angiology. 2000;51:197&#x2013;205. doi: 10.1177/000331970005100303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331970005100303</ArticleId><ArticleId IdType="pubmed">10744007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, et al. Escin attenuates cerebral edema induced by acute omethoate poisoning. Toxicol. Mech. Methods. 2011;21:400&#x2013;405. doi: 10.3109/15376516.2010.550337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15376516.2010.550337</ArticleId><ArticleId IdType="pubmed">21417632</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryavanshi SV, Kulkarni YA. Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats. Life Sci. 2020;254:117777. doi: 10.1016/j.lfs.2020.117777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117777</ArticleId><ArticleId IdType="pubmed">32407839</ArticleId></ArticleIdList></Reference><Reference><Citation>Avci G, Kucukkurt I, KupeliAkkol E, Yesilada E. Effects of escin mixture from the seeds of Aesculus hippocastanum on obesity in mice fed a high fat diet. Pharm. Biol. 2010;48:247&#x2013;252. doi: 10.3109/13880200903085466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13880200903085466</ArticleId><ArticleId IdType="pubmed">20645808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao SQ, et al. Anti-inflammatory effect of external use of escin on cutaneous inflammation: Possible involvement of glucocorticoids receptor. Chin. J. Nat. Med. 2018;16:105&#x2013;112. doi: 10.1016/S1875-5364(18)30036-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-5364(18)30036-0</ArticleId><ArticleId IdType="pubmed">29455725</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Oral administration of escin inhibits acute inflammation and reduces intestinal mucosal injury in animal models. Evid. Based Complement. Altern. Med. 2015;2015:503617. doi: 10.1155/2015/503617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/503617</ArticleId><ArticleId IdType="pmc">PMC4496496</ArticleId><ArticleId IdType="pubmed">26199634</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar GP, Janakiraman U, Essa MM, Justin Thenmozhi A, Manivasagam T. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease. Brain Res. 2014;1585:23&#x2013;36. doi: 10.1016/j.brainres.2014.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.03.010</ArticleId><ArticleId IdType="pubmed">24657313</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CL, et al. Escin induces apoptosis in human bladder cancer cells: An in vitro and in vivo study. Eur. J. Pharmacol. 2018;840:79&#x2013;88. doi: 10.1016/j.ejphar.2018.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2018.09.033</ArticleId><ArticleId IdType="pubmed">30287153</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong DHJ, et al. Molecular targets and anti-cancer potential of escin. Cancer Lett. 2018;422:1&#x2013;8. doi: 10.1016/j.canlet.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.02.027</ArticleId><ArticleId IdType="pubmed">29474858</ArticleId></ArticleIdList></Reference><Reference><Citation>Patlolla JM, et al. Beta-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prev. Res. (Phila) 2013;6:1140&#x2013;1149. doi: 10.1158/1940-6207.CAPR-13-0216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-13-0216</ArticleId><ArticleId IdType="pubmed">23963803</ArticleId></ArticleIdList></Reference><Reference><Citation>Longiave D, Omini C, Nicosia S, Berti F. The mode of action of aescin on isolated veins: Relationship with PGF2 alpha. Pharmacol. Res. Commun. 1978;10:145&#x2013;152. doi: 10.1016/s0031-6989(78)80072-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0031-6989(78)80072-1</ArticleId><ArticleId IdType="pubmed">652841</ArticleId></ArticleIdList></Reference><Reference><Citation>Berti F, Omini C, Longiave D. The mode of action of aescin and the release of prostaglandins. Prostaglandins. 1977;14:241&#x2013;249. doi: 10.1016/0090-6980(77)90169-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-6980(77)90169-1</ArticleId><ArticleId IdType="pubmed">897216</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung. 1994;44:25&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8135874</ArticleId></ArticleIdList></Reference><Reference><Citation>Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: Factors contributing to their efficacy in the treatment of venous insufficiency. Arch. Pharm. (Weinheim) 1995;328:720&#x2013;724. doi: 10.1002/ardp.19953281006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.19953281006</ArticleId><ArticleId IdType="pubmed">8554461</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao GM, Wei J. Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats. J. Zhejiang Univ. Sci. B. 2005;6:28&#x2013;32. doi: 10.1631/jzus.2005.B0028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.2005.B0028</ArticleId><ArticleId IdType="pmc">PMC1390755</ArticleId><ArticleId IdType="pubmed">15593388</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelini FM, Alche LE, Bueno CA. Virucidal, antiviral and immunomodulatory activities of beta-escin and Aesculus hippocastanum extract. J. Pharm. Pharmacol. 2018;70:1561&#x2013;1571. doi: 10.1111/jphp.13002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphp.13002</ArticleId><ArticleId IdType="pubmed">30168142</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas FM, et al. Aesculus hippocastanum L. seed extract shows virucidal and antiviral activities against respiratory syncytial virus (RSV) and reduces lung inflammation in vivo. Antivir. Res. 2019;164:1&#x2013;11. doi: 10.1016/j.antiviral.2019.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.01.018</ArticleId><ArticleId IdType="pubmed">30711418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, et al. Antiviral escin derivatives from the seeds of Aesculus turbinata Blume (Japanese horse chestnut) Bioorg. Med. Chem. Lett. 2017;27:3019&#x2013;3025. doi: 10.1016/j.bmcl.2017.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2017.05.022</ArticleId><ArticleId IdType="pmc">PMC7127610</ArticleId><ArticleId IdType="pubmed">28527823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciftci GA, Iscan A, Kutlu M. Escin reduces cell proliferation and induces apoptosis on glioma and lung adenocarcinoma cell lines. Cytotechnology. 2015;67:893&#x2013;904. doi: 10.1007/s10616-015-9877-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10616-015-9877-6</ArticleId><ArticleId IdType="pmc">PMC4545433</ArticleId><ArticleId IdType="pubmed">25906387</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebert U, Brach M, Sroczynski G, Berla K. Efficacy, routine effectiveness, and safety of horse chestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. Int. Angiol. 2002;21:305&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">12518108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikorska M, et al. Beneficial effects of beta-escin on muscle regeneration in rat model of skeletal muscle injury. Phytomedicine. 2021;93:153791. doi: 10.1016/j.phymed.2021.153791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153791</ArticleId><ArticleId IdType="pubmed">34666284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CY, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. U.S.A. 2004;101:10012&#x2013;10017. doi: 10.1073/pnas.0403596101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403596101</ArticleId><ArticleId IdType="pmc">PMC454157</ArticleId><ArticleId IdType="pubmed">15226499</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera-Lecoin M, Meertens L, Carnec X, Amara A. Flavivirus entry receptors: An update. Viruses. 2013;6:69&#x2013;88. doi: 10.3390/v6010069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6010069</ArticleId><ArticleId IdType="pmc">PMC3917432</ArticleId><ArticleId IdType="pubmed">24381034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel R, et al. Biology of Zika virus infection in human skin cells. J. Virol. 2015;89:8880&#x2013;8896. doi: 10.1128/JVI.00354-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00354-15</ArticleId><ArticleId IdType="pmc">PMC4524089</ArticleId><ArticleId IdType="pubmed">26085147</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J. Flavivirus cell entry and membrane fusion. Viruses. 2011;3:160&#x2013;171. doi: 10.3390/v3020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3020160</ArticleId><ArticleId IdType="pmc">PMC3206597</ArticleId><ArticleId IdType="pubmed">22049308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, et al. Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2017;8:e3113. doi: 10.1038/cddis.2017.488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.488</ArticleId><ArticleId IdType="pmc">PMC5682655</ArticleId><ArticleId IdType="pubmed">29022891</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. Inflammation-induced, STING-dependent autophagy restricts Zika virus infection in the drosophila brain. Cell Host Microbe. 2018;24:57&#x2013;68. doi: 10.1016/j.chom.2018.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.05.022</ArticleId><ArticleId IdType="pmc">PMC6173519</ArticleId><ArticleId IdType="pubmed">29934091</ArticleId></ArticleIdList></Reference><Reference><Citation>Domanski D, et al. Molecular mechanism for cellular response to beta-escin and its therapeutic implications. PLoS&#xa0;One. 2016;11:e0164365. doi: 10.1371/journal.pone.0164365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164365</ArticleId><ArticleId IdType="pmc">PMC5058498</ArticleId><ArticleId IdType="pubmed">27727329</ArticleId></ArticleIdList></Reference><Reference><Citation>Alm E, et al. Universal single-probe RT-PCR assay for diagnosis of dengue virus infections. PLoS Negl. Trop. Dis. 2014;8:e3416. doi: 10.1371/journal.pntd.0003416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003416</ArticleId><ArticleId IdType="pmc">PMC4270494</ArticleId><ArticleId IdType="pubmed">25522325</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>